Chad has an extensive background in analytical chemistry with mass spectrometry as a primary tool, and has served in both the pharmaceutical and clinical diagnostic industries. His work with small molecules has supported ADME/Tox drug discovery and development efforts for many indications. He has developed and validated methods for commercialized macromolecule biomarkers. Chad has a BS in biology from Loyola University Chicago, and an MS in biotechnology from Johns Hopkins University. Outside of work, Chad is interested in all genres of cycling, backpacking, and maybe still a bit of bouldering.
Are you Recursion ready?
Join our passionate, innovative team—and help us realize our goal of 100 treatments by 2025.